ALNA insider filings
Allena Pharmaceuticals, Inc. — 22 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-02-02. Screen ALNA transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ALNA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Allena Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-02-02 | 4 | BRENNER LOUIS MD — President and CEO, Director | Grant/award (A): 655,000 (derivative) @ $0 | EDGAR |
| 2022-02-02 | 4 | Katz Richard D — Chief Financial Officer | Grant/award (A): 255,000 (derivative) @ $0 | EDGAR |
| 2021-11-17 | 4 | BRENNER LOUIS MD — President and CEO, Director | Sale (S): 40,328 @ $0.81 · Option exercise (M): 125,582 · Option exercise (M): 125,582 (derivative) @ $0 | EDGAR |
| 2021-06-04 | 4 | Diaz Allene M. — Director | Grant/award (A): 37,000 (derivative) @ $0 | EDGAR |
| 2021-06-04 | 4 | Miller Ann Calby — Director | Grant/award (A): 37,000 (derivative) @ $0 | EDGAR |
| 2021-06-04 | 4 | Alexander Robert — Director | Grant/award (A): 37,000 (derivative) @ $0 | EDGAR |
| 2021-06-04 | 4 | Margolin Alexey L — Director | Grant/award (A): 37,000 (derivative) @ $0 | EDGAR |
| 2021-06-04 | 4 | SANTINI GINO — Director | Grant/award (A): 37,000 (derivative) @ $0 | EDGAR |
| 2021-05-12 | 4 | BRENNER LOUIS MD — President and COO | Sale (S): 25,215 @ $1.11 · Option exercise (M): 83,721 · Option exercise (M): 83,721 (derivative) @ $0 | EDGAR |
| 2021-04-08 | 4 | Fitzpatrick Mark J. — Director | Grant/award (A): 74,000 (derivative) @ $0 | EDGAR |
| 2021-02-17 | 4 | BRENNER LOUIS MD — President and COO | Grant/award (A): 886,400 (derivative) @ $0 | EDGAR |
| 2021-02-02 | 4 | Katz Richard D — Chief Financial Officer | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2020-12-18 | 4 | WHOLIHAN EDWARD — Chief Financial Officer | Sale (S): 68,550 @ $1.36 · Option exercise (M): 164,822 · Option exercise (M): 164,822 (derivative) @ $0 | EDGAR |
| 2020-12-18 | 4 | BRENNER LOUIS MD — President and CEO | Sale (S): 103,116 @ $1.36 · Option exercise (M): 247,932 · Option exercise (M): 247,932 (derivative) @ $0 | EDGAR |
| 2020-12-10 | 4 | BRENNER LOUIS MD — President and COO | Grant/award (A): 209,303 (derivative) @ $0 | EDGAR |
| 2020-11-18 | 4 | Hack Andrew A. F. — Director | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2020-11-18 | 4 | Diaz Allene M. — Director | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2020-11-18 | 4 | Alexander Robert — Director | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2020-11-18 | 4 | Margolin Alexey L — Director | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2020-11-18 | 4 | Topper James N — Director, 10% owner | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2020-11-18 | 4 | SANTINI GINO — Director | Grant/award (A): 14,000 (derivative) @ $0 | EDGAR |
| 2020-10-06 | 4 | Miller Ann Calby — Director | Grant/award (A): 28,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Allena Pharmaceuticals, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2022-09-07 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2022-09-02 | 8-K | 1.02 — Termination of a Material Definitive Agreement 1.03 — Bankruptcy or Receivership 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2022-08-24 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2022-08-11 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-08-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2022-07-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-07-11 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-07-08 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-07-05 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-06-28 | 8-K | 1.02 — Termination of a Material Definitive Agreement | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ALNA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs